img

Global Endothelial Dysfunction Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Endothelial Dysfunction Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Endothelium is an inert lining of the blood vessels which act as highly specialized and metabolically active interface between the blood and the underlying tissues. The basic activities of endothelium encompass mediation of coagulation, platelet adhesion, immune function and control of volume and electrolyte content of the intravascular and extravascular spaces. Endothelium dysfunction can be defined as partial or complete loss of balance between vasodilating and vasoconstricting substances produced by the endothelium.
Global Endothelial Dysfunction market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Hospital and Clinic are the major drivers for the industry.
Geographically, the North American and European markets are currently the major markets for endothelial dysfunction products due to their high R&D involvement, advanced medical facilities, and wide awareness of cardiovascular diseases and other related diseases. Lack of government intervention and funding for R&D affects growth and income shares in emerging and developing countries. With the substantial increase in cardiovascular and diabetes cases in Asia Pacific and Middle East countries in the coming years, the demand for the endothelial dysfunction market in these regions is likely to grow over the next seven years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Endothelial Dysfunction market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott Laboratories
Chugai Pharmaceutical
Johnson & Johnson
Glucox Biotech AB
Stealth Peptides
Segment by Type
Western Medicine Treatment
Chinese Medicine Treatment

Segment by Application


Hospital
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Endothelial Dysfunction market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Endothelial Dysfunction introduction, etc. Endothelial Dysfunction Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Endothelial Dysfunction market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Endothelial Dysfunction
1.1 Endothelial Dysfunction Market Overview
1.1.1 Endothelial Dysfunction Product Scope
1.1.2 Endothelial Dysfunction Market Status and Outlook
1.2 Global Endothelial Dysfunction Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Endothelial Dysfunction Market Size by Region (2018-2033)
1.4 Global Endothelial Dysfunction Historic Market Size by Region (2018-2023)
1.5 Global Endothelial Dysfunction Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Endothelial Dysfunction Market Size (2018-2033)
1.6.1 North America Endothelial Dysfunction Market Size (2018-2033)
1.6.2 Europe Endothelial Dysfunction Market Size (2018-2033)
1.6.3 Asia-Pacific Endothelial Dysfunction Market Size (2018-2033)
1.6.4 Latin America Endothelial Dysfunction Market Size (2018-2033)
1.6.5 Middle East & Africa Endothelial Dysfunction Market Size (2018-2033)
2 Endothelial Dysfunction Market by Type
2.1 Introduction
2.1.1 Western Medicine Treatment
2.1.2 Chinese Medicine Treatment
2.2 Global Endothelial Dysfunction Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Endothelial Dysfunction Historic Market Size by Type (2018-2023)
2.2.2 Global Endothelial Dysfunction Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Endothelial Dysfunction Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Endothelial Dysfunction Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Endothelial Dysfunction Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Endothelial Dysfunction Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Endothelial Dysfunction Revenue Breakdown by Type (2018-2033)
3 Endothelial Dysfunction Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.2 Global Endothelial Dysfunction Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Endothelial Dysfunction Historic Market Size by Application (2018-2023)
3.2.2 Global Endothelial Dysfunction Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Endothelial Dysfunction Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Endothelial Dysfunction Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Endothelial Dysfunction Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Endothelial Dysfunction Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Endothelial Dysfunction Revenue Breakdown by Application (2018-2033)
4 Endothelial Dysfunction Competition Analysis by Players
4.1 Global Endothelial Dysfunction Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Endothelial Dysfunction as of 2022)
4.3 Date of Key Players Enter into Endothelial Dysfunction Market
4.4 Global Top Players Endothelial Dysfunction Headquarters and Area Served
4.5 Key Players Endothelial Dysfunction Product Solution and Service
4.6 Competitive Status
4.6.1 Endothelial Dysfunction Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Endothelial Dysfunction Products, Services and Solutions
5.1.4 Abbott Laboratories Endothelial Dysfunction Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Chugai Pharmaceutical
5.2.1 Chugai Pharmaceutical Profile
5.2.2 Chugai Pharmaceutical Main Business
5.2.3 Chugai Pharmaceutical Endothelial Dysfunction Products, Services and Solutions
5.2.4 Chugai Pharmaceutical Endothelial Dysfunction Revenue (US$ Million) & (2018-2023)
5.2.5 Chugai Pharmaceutical Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Endothelial Dysfunction Products, Services and Solutions
5.3.4 Johnson & Johnson Endothelial Dysfunction Revenue (US$ Million) & (2018-2023)
5.3.5 Glucox Biotech AB Recent Developments
5.4 Glucox Biotech AB
5.4.1 Glucox Biotech AB Profile
5.4.2 Glucox Biotech AB Main Business
5.4.3 Glucox Biotech AB Endothelial Dysfunction Products, Services and Solutions
5.4.4 Glucox Biotech AB Endothelial Dysfunction Revenue (US$ Million) & (2018-2023)
5.4.5 Glucox Biotech AB Recent Developments
5.5 Stealth Peptides
5.5.1 Stealth Peptides Profile
5.5.2 Stealth Peptides Main Business
5.5.3 Stealth Peptides Endothelial Dysfunction Products, Services and Solutions
5.5.4 Stealth Peptides Endothelial Dysfunction Revenue (US$ Million) & (2018-2023)
5.5.5 Stealth Peptides Recent Developments
6 North America
6.1 North America Endothelial Dysfunction Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Endothelial Dysfunction Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Endothelial Dysfunction Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Endothelial Dysfunction Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Endothelial Dysfunction Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Endothelial Dysfunction Market Dynamics
11.1 Endothelial Dysfunction Industry Trends
11.2 Endothelial Dysfunction Market Drivers
11.3 Endothelial Dysfunction Market Challenges
11.4 Endothelial Dysfunction Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Endothelial Dysfunction Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Endothelial Dysfunction Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Endothelial Dysfunction Market Size Share by Region (2018-2023)
Table 4. Global Endothelial Dysfunction Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Endothelial Dysfunction Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Endothelial Dysfunction Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Endothelial Dysfunction Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Endothelial Dysfunction Revenue Market Share by Type (2018-2023)
Table 9. Global Endothelial Dysfunction Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Endothelial Dysfunction Revenue Market Share by Type (2024-2033)
Table 11. North America Endothelial Dysfunction Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Endothelial Dysfunction Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Endothelial Dysfunction Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Endothelial Dysfunction Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Endothelial Dysfunction Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Endothelial Dysfunction Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Endothelial Dysfunction Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Endothelial Dysfunction Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Endothelial Dysfunction Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Endothelial Dysfunction Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Endothelial Dysfunction Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Endothelial Dysfunction Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Endothelial Dysfunction Revenue Market Share by Application (2018-2023)
Table 24. Global Endothelial Dysfunction Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Endothelial Dysfunction Revenue Market Share by Application (2024-2033)
Table 26. North America Endothelial Dysfunction Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Endothelial Dysfunction Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Endothelial Dysfunction Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Endothelial Dysfunction Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Endothelial Dysfunction Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Endothelial Dysfunction Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Endothelial Dysfunction Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Endothelial Dysfunction Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Endothelial Dysfunction Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Endothelial Dysfunction Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Endothelial Dysfunction Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Endothelial Dysfunction Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Endothelial Dysfunction as of 2022)
Table 39. Date of Key Players Enter into Endothelial Dysfunction Market
Table 40. Global Endothelial Dysfunction Key Players Headquarters and Area Served
Table 41. Endothelial Dysfunction Product Solution and Service
Table 42. Global Endothelial Dysfunction Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Abbott Laboratories Basic Information List
Table 45. Abbott Laboratories Description and Business Overview
Table 46. Abbott Laboratories Endothelial Dysfunction Products, Services and Solutions
Table 47. Revenue (US$ Million) in Endothelial Dysfunction Business of Abbott Laboratories (2018-2023)
Table 48. Abbott Laboratories Recent Developments
Table 49. Chugai Pharmaceutical Basic Information List
Table 50. Chugai Pharmaceutical Description and Business Overview
Table 51. Chugai Pharmaceutical Endothelial Dysfunction Products, Services and Solutions
Table 52. Revenue (US$ Million) in Endothelial Dysfunction Business of Chugai Pharmaceutical (2018-2023)
Table 53. Chugai Pharmaceutical Recent Developments
Table 54. Johnson & Johnson Basic Information List
Table 55. Johnson & Johnson Description and Business Overview
Table 56. Johnson & Johnson Endothelial Dysfunction Products, Services and Solutions
Table 57. Revenue (US$ Million) in Endothelial Dysfunction Business of Johnson & Johnson (2018-2023)
Table 58. Johnson & Johnson Recent Developments
Table 59. Glucox Biotech AB Basic Information List
Table 60. Glucox Biotech AB Description and Business Overview
Table 61. Glucox Biotech AB Endothelial Dysfunction Products, Services and Solutions
Table 62. Revenue (US$ Million) in Endothelial Dysfunction Business of Glucox Biotech AB (2018-2023)
Table 63. Glucox Biotech AB Recent Developments
Table 64. Stealth Peptides Basic Information List
Table 65. Stealth Peptides Description and Business Overview
Table 66. Stealth Peptides Endothelial Dysfunction Products, Services and Solutions
Table 67. Revenue (US$ Million) in Endothelial Dysfunction Business of Stealth Peptides (2018-2023)
Table 68. Stealth Peptides Recent Developments
Table 69. North America Endothelial Dysfunction Market Size by Country (2018-2023) & (US$ Million)
Table 70. North America Endothelial Dysfunction Market Size by Country (2024-2033) & (US$ Million)
Table 71. Europe Endothelial Dysfunction Market Size by Country (2018-2023) & (US$ Million)
Table 72. Europe Endothelial Dysfunction Market Size by Country (2024-2033) & (US$ Million)
Table 73. Asia-Pacific Endothelial Dysfunction Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 74. Asia-Pacific Endothelial Dysfunction Market Size by Region (2018-2023) & (US$ Million)
Table 75. Asia-Pacific Endothelial Dysfunction Market Size by Region (2024-2033) & (US$ Million)
Table 76. Asia-Pacific Endothelial Dysfunction Market Share by Region (2018-2023)
Table 77. Asia-Pacific Endothelial Dysfunction Market Share by Region (2024-2033)
Table 78. Latin America Endothelial Dysfunction Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 79. Latin America Endothelial Dysfunction Market Size by Country (2018-2023) & (US$ Million)
Table 80. Latin America Endothelial Dysfunction Market Size by Country (2024-2033) & (US$ Million)
Table 81. Middle East & Africa Endothelial Dysfunction Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 82. Middle East & Africa Endothelial Dysfunction Market Size by Country (2018-2023) & (US$ Million)
Table 83. Middle East & Africa Endothelial Dysfunction Market Size by Country (2024-2033) & (US$ Million)
Table 84. Endothelial Dysfunction Market Trends
Table 85. Endothelial Dysfunction Market Drivers
Table 86. Endothelial Dysfunction Market Challenges
Table 87. Endothelial Dysfunction Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endothelial Dysfunction Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Endothelial Dysfunction Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Endothelial Dysfunction Market Share by Regions: 2022 VS 2033
Figure 4. Global Endothelial Dysfunction Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Endothelial Dysfunction Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Endothelial Dysfunction Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Endothelial Dysfunction Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Endothelial Dysfunction Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Endothelial Dysfunction Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Western Medicine Treatment
Figure 11. Global Western Medicine Treatment Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Chinese Medicine Treatment
Figure 13. Global Chinese Medicine Treatment Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Endothelial Dysfunction Market Size Share by Type: 2022 & 2033
Figure 15. North America Endothelial Dysfunction Revenue Market Share by Type (2018-2033)
Figure 16. Europe Endothelial Dysfunction Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Endothelial Dysfunction Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Endothelial Dysfunction Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Endothelial Dysfunction Revenue Market Share by Type (2018-2033)
Figure 20. Hospital Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Clinic Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Global Endothelial Dysfunction Market Size Share by Application: 2022 & 2033
Figure 23. North America Endothelial Dysfunction Revenue Market Share by Application (2018-2033)
Figure 24. Europe Endothelial Dysfunction Revenue Market Share by Application (2018-2033)
Figure 25. Asia-Pacific Endothelial Dysfunction Revenue Market Share by Application (2018-2033)
Figure 26. Latin America Endothelial Dysfunction Revenue Market Share by Application (2018-2033)
Figure 27. Middle East and Africa Endothelial Dysfunction Revenue Market Share by Application (2018-2033)
Figure 28. Endothelial Dysfunction Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 29. Global Top 5 and Top 10 Players Endothelial Dysfunction Market Share in 2022
Figure 30. North America Endothelial Dysfunction Market Share by Country (2018-2033)
Figure 31. U.S. Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 32. Canada Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 33. Germany Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 34. France Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 35. U.K. Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 36. Italy Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 37. Russia Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 38. Nordic Countries Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Endothelial Dysfunction Market Share by Region (2018-2033)
Figure 40. China Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 41. Japan Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 42. South Korea Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 44. India Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 45. Australia Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 46. Latin America Endothelial Dysfunction Market Share by Country (2018-2033)
Figure 47. Mexico Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 48. Brazil Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa Endothelial Dysfunction Market Share by Country (2018-2033)
Figure 50. Turkey Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 51. Saudi Arabia Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 52. UAE Endothelial Dysfunction Market Size (2018-2033) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report